HoldingsChannel.com
All Stocks Held By Finepoint Capital LP
As of  12/31/2023, we find all stocks held by Finepoint Capital LP to be as follows, presented in the table below with each row detailing each Finepoint Capital LP position, ordered by largest to smallest position size. The all-stocks-held-by-Finepoint Capital LP table shows the entity held in the first column (click any entity to explore other funds holding positions), the share amount held, the share count change between the last two reporting periods, and finally the position size for all stocks held by Finepoint Capital LP as of the latest filing.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
MOONLAKE IMMUNOTHERAPEUTICS 895,000 +563,584 $54,049
     MLTX895,000+563,584$54,049
CYTOKINETICS INC 431,693 UNCH $36,042
     CYTK431,693UNCH$36,042
SPIRIT AIRLINES INC      $27,863
     Call1,700,000+1,700,000$27,863
ACADIA PHARMACEUTICALS INC 769,653 +213,100 $24,098
     ACAD769,653+213,100$24,098
AMICUS THERAPEUTICS INC 1,489,025 UNCH $21,129
     FOLD1,489,025UNCH$21,129
ARVINAS INC 504,700 UNCH $20,773
     ARVN504,700UNCH$20,773
ASCENDIS PHARMA A S 163,772 UNCH $20,627
     ASND163,772UNCH$20,627
SPRINGWORKS THERAPEUTICS INC 556,928 UNCH $20,328
     SWTX556,928UNCH$20,328
GALAPAGOS NV 458,659 UNCH $18,644
     GLPG458,659UNCH$18,644
REVOLUTION MEDICINES INC 617,100 +190,100 $17,698
     RVMD617,100+190,100$17,698
LIBERTY BROADBAND CORP 184,460 +184,460 $14,866
     LBRDK184,460+184,460$14,866
RELAY THERAPEUTICS INC 1,317,870 +447,000 $14,510
     RLAY1,317,870+447,000$14,510
MORPHIC HOLDING INC 496,856 +171,500 $14,349
     MORF496,856+171,500$14,349
SAREPTA THERAPEUTICS INC 145,357 UNCH $14,017
     SRPT145,357UNCH$14,017
TRAVERE THERAPEUTICS INC 1,435,321 +539,500 $12,904
     TVTX1,435,321+539,500$12,904
PROTHENA CORP PLC 349,300 UNCH $12,694
     PRTA349,300UNCH$12,694
SOLID BIOSCIENCES INC 961,251 UNCH $5,902
     SLDB961,251UNCH$5,902
CALIDI BIOTHERAPEUTICS INC      $1,033
     FLAG125,000UNCH$1,000
     FLAG.WT655,200UNCH$33
CHURCHILL CAPITAL CORP VII      $71
     CVII.WT548,000UNCH$71
CONCORD ACQUISITION CORP II      $53
     CNDA.WT408,333UNCH$53
ROSS ACQUISITION CORP II      $25
     ROSS.WT439,666UNCH$25
MARBLEGATE ACQUISITION CORP 735,000 UNCH $22
     GATEW735,000UNCH$22
COMPASS DIGITAL ACQUISITION CORP 459,906 UNCH <$1
     CDAQW459,906UNCH$0
HOME PLATE ACQUISITION CORP 331,416 -358,584 <$1
     HPLTW331,416-358,584$0
SWIFTMERGE ACQUISITION CORP 490,000 UNCH <$1
     IVCPW490,000UNCH$0
YS BIOPHARMA CO LTD 489,999 +0 $0
     YSBPW489,999UNCH$0
ARES ACQUISITION CORP $0 (exited)
     AAC.WT0-504,706$0
BRIDGETOWN HOLDINGS LTD $0 (exited)
     BTWNW0-895,000$0
CHURCHILL CAPITAL CORP V $0 (exited)
     CCV.WT0-612,000$0
CHURCHILL CAPITAL CORP VI $0 (exited)
     CCVI.WT0-540,000$0
CEREVEL THERAPEUTICS HLDNG I $0 (exited)
     CERE0-563,345$0

See Summary: Finepoint Capital LP Top Holdings
See Details: Top 10 Stocks Held By Finepoint Capital LP

EntityShares/Amount
Change
Position Value
Change
SAVE +1,700,000+$27,863
LBRDK +184,460+$14,866
EntityShares/Amount
Change
Position Value
Change
CERE -563,345-$12,298
AAC -504,706-$334
BTWNW -895,000-$304
CCVI -540,000-$86
YSBPW -489,999$UNCH
CCV -612,000$UNCH
EntityShares/Amount
Change
Position Value
Change
MLTX +563,584+$35,158
TVTX +539,500+$4,895
RLAY +447,000+$7,186
ACAD +213,100+$12,499
RVMD +190,100+$5,879
MORF +171,500+$6,895
CYTK UNCH+$23,324
FOLD UNCH+$3,022
ARVN UNCH+$10,861
ASND UNCH+$5,291
EntityShares/Amount
Change
Position Value
Change
HPLTW -358,584$UNCH
YSBPW UNCH$UNCH
IVCPW UNCH$UNCH
CDAQW UNCH$UNCH
GATEW UNCH-$15
ROSS UNCH-$24
CNDA UNCH+$10
CVII UNCH-$98
FLAG UNCH-$111
Size ($ in 1000's)
At 12/31/2023: $351,697
At 09/30/2023: $201,252

Finepoint Capital LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Finepoint Capital LP 13F filings. Link to 13F filings: SEC filings

All Stocks Held By Finepoint Capital LP | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.